Collegium Pharmaceutical, Inc. (COLL) Total liabilities 2016–2025
Collegium Pharmaceutical, Inc. (COLL) total liabilities at each fiscal year-end, per SEC filings.
$1.4BFY2025 · since FY2016: $27.1M → $1.4B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.4B | -5.5% |
| FY2024 | $1.4B | +51.4% |
| FY2023 | $947.9M | -3.2% |
| FY2022 | $979.3M | +100.2% |
| FY2021 | $489.1M | +6.8% |
| FY2020 | $457.8M | +109.2% |
| FY2019 | $218.9M | +9.6% |
| FY2018 | $199.7M | +534.1% |
| FY2017 | $31.5M | +16.2% |
| FY2016 | $27.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice